Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-039770

Director acquired 3,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sanders Corazon (Corsee) D. Director 2022-06-24 Grant or award +3,300 7,195 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sanders Corazon (Corsee) D. Director 2022-06-24 Grant or award · Stock Option (Right to Buy) +6,245 6,245 D: show line 2 in the form
Loading xslF345X03/doc4.xml…